agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 117.20% | 303.86% | -78.54% | -- | -240.17% |
| Total Depreciation and Amortization | -6.22% | -1.29% | -68.02% | -- | 23.90% |
| Total Amortization of Deferred Charges | -- | -- | 30.48% | -- | -- |
| Total Other Non-Cash Items | 250.61% | -93.31% | 691.06% | -- | -9.41% |
| Change in Net Operating Assets | -315.59% | 78.27% | -21.84% | -- | 1,429.52% |
| Cash from Operations | -63.31% | 174.18% | -225.08% | -- | -87.45% |
| Capital Expenditure | -6.06% | 19.43% | 9.12% | -- | 1.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.31% | 216.28% | -5.15% | -- | 242.37% |
| Cash from Investing | -71.74% | 183.47% | -4.60% | -- | 286.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 101.36% | -922.98% | -- | -- | -- |
| Cash from Financing | 279.50% | -3,096.89% | 22.73% | -- | -50.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.88% | 168.53% | -94.94% | -- | 1,581.17% |